Please use this identifier to cite or link to this item:
Title: A bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer
Authors: Chan, K
Shah, K
Lien, K
Coyle, D
Lam, H
Ko, Y-J
Keywords: Pancreatic cancer;Parmar method;Systemic regimens;Gemcitabine;Randomized controlled trials;Bayesian meta-analysis
Issue Date: 2014
Publisher: Public Library of Science
Citation: PLoS ONE, 9(10): e108749, (2014)
Abstract: Background: For advanced pancreatic cancer, many regimens have been compared with gemcitabine (G) as the standard arm in randomized controlled trials. Few regimens have been directly compared with each other in randomized controlled trials and the relative efficacy and safety among them remains unclear.
Description: © 2014 Chan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
ISSN: 1932-6203
Appears in Collections:Publications
Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdf938.16 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.